Skip to main content
VCbacked
Log inGet Started

Dynocardia

Cambridge, United States

Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.

$675K raised
Mar 2025
Venture - Series Unknown
BiotechnologyHealth CareMedical DevicePersonal HealthWearables

Top Investors

National Science FoundationMassachusetts Medical Device Development Center (M2D2)LuminateNational HeartLung and Blood InstituteMayo Clinic Platform

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dynocardia

How much funding has Dynocardia raised?
Dynocardia has raised $675K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Who are Dynocardia's investors?
Dynocardia's investors include National Science Foundation, Massachusetts Medical Device Development Center (M2D2), Luminate, National Heart, Lung and Blood Institute, Mayo Clinic Platform.
Where is Dynocardia headquartered?
Dynocardia is headquartered in Cambridge, United States.
What does Dynocardia do?
Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.
What stage is Dynocardia at?
Dynocardia is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dynocardia — Funding & Investors." VCBacked, March 14, 2025, https://www.vcbacked.co/company/dynocardia. Accessed June 4, 2026.
APA
VCBacked. (2025). Dynocardia — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/dynocardia
Wikipedia (cite web)
{{cite web |title=Dynocardia — Funding & Investors |url=https://www.vcbacked.co/company/dynocardia |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong